Obesity in Patients with COVID-19

Obesity raises the likelihood of hospitalisation, ICU admission, IMV therapy, and death in COVID-19 patients. Furthermore, excessive visceral adiposity appears to be connected to poor COVID-19 outcomes. These findings highlight the importance of individuals, the general public, and governments taking effective measures to raise awareness of the hazards associated with obesity and how they are exacerbated in the current worldwide epidemic. Obesity is frequent among coronavirus patients in 2019 (COVID-19). Obesity's impact on COVID-19 clinical outcomes warrants further investigation.

  • Coronavirus disease 2019
  • Intensive care
  • Mortality
  • Obesity
  • Visceral adipose tissue

Related Conference of Obesity in Patients with COVID-19

June 02-03, 2025

21st Euro Obesity and Endocrinology Congress

Amsterdam, Netherlands
November 20-21, 2025

11th International Conference on Gynecology and Obstetrics

Aix-en-Provence, France
March 26-27, 2026

28th Global Obesity Meeting

London, UK

Obesity in Patients with COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in